The Enterprise Value as of September 2024 (TTM) for EQRx, Inc. (EQRX) is 826.94M

According to EQRx, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 826.94M. This represents a change of 24.14% compared to the average of 666.13M of the last 4 quarters.

EQRx, Inc. (EQRX) Historical Enterprise Value (quarterly & annually)

How has EQRX Enterprise Value performed in the past?

The mean historical Enterprise Value of EQRx, Inc. over the last ten years is 968.44M. The current 826.94M Enterprise Value has changed 8.44% with respect to the historical average. Over the past ten years (40 quarters), EQRX's Enterprise Value was at its highest in in the September 2021 quarter at 4.38B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.

EQRx, Inc. (EQRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of EQRx, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

EQRx, Inc. (EQRX) Average Enterprise Value

How has EQRX Enterprise Value performed in the past?

The current Enterprise Value of EQRx, Inc. (EQRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

EQRx, Inc. (EQRX) Enterprise Value vs. Peers

How is EQRX’s Enterprise Value compared to its peers?

EQRx, Inc.’s Enterprise Value is greater than Century Therapeutics, Inc. (138.60M), less than Edgewise Therapeutics, Inc. (1.60B), greater than C4 Therapeutics, Inc. (369.73M), greater than Mineralys Therapeutics, Inc. (490.57M), less than Cullinan Oncology, Inc. (930.13M), greater than Lyell Immunopharma, Inc. (226.32M), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Theseus Pharmaceuticals, Inc. (138.26M), less than Revolution Medicines, Inc. (6.80B), greater than Relay Therapeutics, Inc. (752.45M), greater than Stoke Therapeutics, Inc. (586.20M), greater than Pliant Therapeutics, Inc. (762.35M), greater than Black Diamond Therapeutics, Inc. (296.10M), less than Arvinas, Inc. (1.52B), less than Blueprint Medicines Corporation (6.16B), less than Sana Biotechnology, Inc. (1.08B), less than Kymera Therapeutics, Inc. (2.92B), greater than Erasca, Inc. (689.13M), greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Keros Therapeutics, Inc. (1.58B),

Build a custom stock screener for EQRx, Inc. (EQRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EQRx, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EQRx, Inc. (EQRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EQRx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.